Zobrazeno 1 - 10
of 23
pro vyhledávání: '"OPV, oral polio vaccine"'
Autor:
Maria Dolores Fernandez-Garcia, Martin Faye, Francisco Diez-Fuertes, Antonio Moreno-Docón, Maria Dolores Chirlaque-López, Ousmane Faye, Maria Cabrerizo
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionIn 2021, a type 2 vaccine-derived poliovirus (VDPV2) was isolated from the stool of a patient with acute flaccid paralysis (AFP) admitted to Spain from Senegal. A virological investigation was conducted to characterize and trace the origi
Externí odkaz:
https://doaj.org/article/bc18d7ca07f64169b76d83122d9575bf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rahul Pradhan, Jhalak Sharma Gautam, Anindya Sekhar Bose, Bhim Singh Tinkari, Neelam Adhikari
Publikováno v:
Vaccine
Highlights • Sixteen AEFI cases (21%) with symptom or sign of bleeding were reported in 2016–2018. • Six (38%) had intra-cranial haemorrhage; 14 (88%) had bleeding from injection site. • Only one case (6%) had confirmed history of receiving v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed212c90d255ceaf05b8ec1b2f4df0be
https://pubmed.ncbi.nlm.nih.gov/32788134
https://pubmed.ncbi.nlm.nih.gov/32788134
Autor:
Goldwood, Geneva, Diesburg, Steven
Publikováno v:
Vaccine
Cool water packs are a useful alternative to ice packs for preventing unintentional freezing of vaccines during outreach in some situations. Current guidelines recommend the use of a separate refrigerator for cooling water packs from ambient temperat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffca9b5914285b3adc12552cbe8e1a13
http://europepmc.org/articles/PMC5736983
http://europepmc.org/articles/PMC5736983
Autor:
Hoest, Christel, Seidman, Jessica C., Lee, Gwenyth, Platts-Mills, James A, Ali, Asad, Olortegui, Maribel Paredes, Bessong, Pascal, Chandyo, Ram, Babji, Sudhir, Mohan, Venkata Raghava, Mondal, Dinesh, Mahfuz, Mustafa, Mduma, Estomih R, Nyathi, Emanuel, Abreu, Claudia, Miller, Mark A., Pan, William, Mason, Carl J., Knobler, Stacey L.
Publikováno v:
Vaccine
Background Launched in 1974, the Expanded Program on Immunization (EPI) is estimated to prevent two-three million deaths annually from polio, diphtheria, tuberculosis, pertussis, measles, and tetanus. Additional lives could be saved through better un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::036ffdc6eb694df1d4061f6f00d7aa5f
Autor:
Tahmeena Farooqi, Kannan R.R. Rengasamy, Sirajudheen Anwar, Faheem Hyder Pottoo, Jonaid Ahmad Malik, Almas Hanif Mulla
Publikováno v:
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy, Vol 137, Iss, Pp 111254-(2021)
Biomedicine & Pharmacotherapy, Vol 137, Iss, Pp 111254-(2021)
Graphical abstract
Highlights • The potential antigen targets are being utilized for the formulation of an effective vaccine. Spike protein is the most utilized antigen target for vaccine development, however other structural and non-structura
Highlights • The potential antigen targets are being utilized for the formulation of an effective vaccine. Spike protein is the most utilized antigen target for vaccine development, however other structural and non-structura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ab65f9901da2f7c2301716f0c92c14
https://doi.org/10.1016/j.biopha.2021.111254
https://doi.org/10.1016/j.biopha.2021.111254
Autor:
William A. Petri, Jashim Uddin, Dorothy M. Dickson, Sharmin Begum, E. Ross Colgate, Rashidul Haque, Mami Taniuchi, Eric R. Houpt, Beth D. Kirkpatrick, Uma Nayak, Marya P. Carmolli, Shihab U. Sobuz, James A Platts-Mills, Jie Liu
Publikováno v:
Vaccine
Highlights • Oral vaccines exhibit poor performance in low-income settings. • Enterovirus and Campylobacter carriage are associated with lower OPV immunogenicity. • Enterovirus carriage is associated with lower Rotarix immunogenicity and effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b350159b71d7ee592cf1876396ac2a6
https://doi.org/10.1016/j.vaccine.2016.04.080
https://doi.org/10.1016/j.vaccine.2016.04.080
Autor:
Abdullah B Naveed, Samina Junejo, Farah Naz Qamar, Khalid Saleem, Sonia Qureshi, Fatima Mir, Khalil Ahmad, Samreen Kulsom Zaidi
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 7, Pp 100133-(2020)
The World Allergy Organization Journal
The World Allergy Organization Journal
Background Primary Immunodeficiency Disorders (PIDs) are well-known disorders in the West. but the recognition and diagnosis of these disorders is challenging in developing countries. We present the spectrum of PIDs seen at a tertiary care center in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a4fe362d7732f7898983fd3fe55fa3
https://doi.org/10.1016/j.waojou.2020.100133
https://doi.org/10.1016/j.waojou.2020.100133
Publikováno v:
Vaccine
Bacillus Calmette-Guerin (BCG) vaccination has been reported to protect neonates from non-tuberculous pathogens, but no biological mechanism to explain such effects is known. We hypothesised that BCG produces broad-spectrum anti-microbial protection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a0e07f80bd0d79be08437b024f27122a
Publikováno v:
Sørup, S, Benn, C S, Stensballe, L G, Aaby, P & Ravn, H 2015, ' Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact ', Vaccine, vol. 33, no. 1, pp. 237-245 . https://doi.org/10.1016/j.vaccine.2014.07.110
Vaccine
Vaccine
Highlights • MMR vaccination is given to protect against measles, mumps and rubella. • RSV is an important cause of acute lower respiratory infections in young children. • MMR vaccination was associated with 22% lower rate of RSV hospital conta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::773e30d4cb5f2c64fb10a097a2e6a937
https://doi.org/10.1016/j.vaccine.2014.07.110
https://doi.org/10.1016/j.vaccine.2014.07.110